Playlist


Turkmen Akhal-Teke Horses to Feature in International Competition in Tashkent
02 May. 07:05Turkmenistan is set to participate in the international equestrian sports and beauty contest titled "Pearl of the East," scheduled for May 9–10, 2026, in Tashkent, Uzbekistan. According to the TDH news agency, the Turkmen delegation will also attend a dedicated conference titled "The Akhal-Teke Horse — A Symbol of Friendship Between Nations." This initiative aims to strengthen cultural ties and celebrate the shared equestrian heritage of the region.
During a government meeting, Deputy Chairman of the Cabinet of Ministers T. Atahallyev reported on the ongoing preparations for the upcoming trip. President Serdar Berdimuhamedov instructed the Vice-Premier to ensure the successful participation of Turkmen breeders and the legendary Akhal-Teke horses in these international events. The President emphasized that such platforms are vital for showcasing Turkmenistan’s achievements in the art of horse breeding to the global community.
The involvement of Akhal-Teke horses in the Tashkent festival highlights the global prestige of Turkmenistan’s national pride. These "heavenly horses" continue to serve as ambassadors of culture and history, promoting friendship and cooperation through the medium of sport and traditional art. The event in Uzbekistan is expected to be a significant milestone in fostering academic and professional exchange among equestrian experts across Central Asia.


Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.